AD retweeted
The latest issue of PharmacoEconomics Open
#OpenSourceModels
#HTA
#DrugPricing
#EconomicEvaluation
#HealthEconomics
link.springer.com/journal/41…
AD retweeted
🏅We have been awarded a medal for sustainability for placing top 30% of companies rated by @ecovadis! We were assessed across 21 indicators in ethics, labour & human rights, and the environment. Read more: bit.ly/46DRQnl
#HEOR #healthcare #consulting #pharmaceuticals
AD retweeted
The July issue of AHEHP includes assessments of:
- devices in paediatric patients
- combination cancer therapies
- CE thresholds
- childhood MAUIs
- COVID-19 certificate preferences
- distributional CEA
- cannabis vape preferences
link.springer.com/journal/40…
AD retweeted
The March issue of PharmacoEconomics Open covers a range on interventions including:
digital health interventions
orphan drugs
stem cell transplants
immunotherapies
dance and yoga
link.springer.com/journal/41…
#HealthEconomics
AD retweeted
#WorldEPACongress is finally happening next week!
Do you want to know who is lucky enough to travel to Amsterdam from our team with @EurostarUK? Have a look below 🚅
If you catch us at the #conference don’t be shy and say hi! 👀
#HEOR #healthcare #pharmaceuticals #consulting
AD retweeted
March issue of AHEHP has a great variety of articles! link.springer.com/journal/40… #HealthEconomics #HealthPolicy
AD retweeted
Today is #RareDiseaseDay, a day to raise awareness for the 300 million people living with rare diseases.
At Symmetron, we work hard to support the appropriate allocation and access to effective treatment for patients with rare diseases. Read here: bit.ly/3EvHoC4
AD retweeted
This article by @LeonardColm et al. is accompanied by a commentary by @koutterson and @JohnRex_NewAbx link.springer.com/article/10… #AMR
Antimicrobial resistance or #AMR, as known in short, is a global health crisis.
Find out how we're applying a new 'Netflix' style payment model to boost the antimicrobial pipeline, which has already assessed 2 new antimicrobial drugs⬇️
link.springer.com/article/10…
AD retweeted
Have you bookmarked our newest glossary yet? Try our quiz below to check whether you need to refresh your memory 🧠. Read here now: bit.ly/3lit0q3
#NICE #qaly #healthcare #pharmaceuticals
One quality-adjusted life year is defined as:
0%Price of 1 human life
100%1 year in full health
0%Total health of 1 patient
1 votes • Final results AD retweeted
🚨 New publication 🚨 In collaboration with #LivaNova, our team evaluated the cost-effectiveness of vagus nerve stimulation (VNS) treatment now published with the #JME.
Publication: bit.ly/3xo0ZQJ
#HEOR #healthcare #epilepsy #medicaldevices
AD retweeted
Have you ever been listed as an author on an article when you probably don't qualify for authorship status? (regardless of whose fault it was)
33%Yes
14%Maybe
53%No
36 votes • Final results AD retweeted
Do you often read HEOR-related content? Do you want to gain further insight on specific technical terms ?
Whether you are just starting your career in HEOR or are a seasoned consultant, read and bookmark our latest glossary here: symmetron.net/2023/01/09/glo…
#HEOR #healthcare
AD retweeted
Rather than a poll, here's a qualitative question. What's your favourite #HealthEconomics conference and why?
AD retweeted
The poll we conducted a few days ago on LinkedIn revealed that 55% of people who engaged took more than 5 hours to run a DES model.
Do you want to know how to reduce run-time? Find out here: symmetron.net/2022/11/01/clo…
#HEOR #healthcare #consulting #cloudcomputing
Old Shoes by Tom Waits must objectively be the most heart-wrenching song ever. Honest and brutal.
#tomwaits #brutalsongs
AD retweeted
What does the path of a bicycle pushed until it falls over look like? These are the paths of 800 unsteered bicycles obtained by CalTech's Matthew Cook
[full paper: ow.ly/WOfV50CgppT]
AD retweeted
Thank you to everyone who joined our sessions at #ISPOREurope yesterday, we hope you enjoyed our presentations!
Today we covered a wide range of topics, which you can read more about here: bit.ly/3T1TWG3
AD retweeted
Meet Kirsten, who will be presenting “NICE Immuno-Oncology Appraisals: Comparison of Progression-Free Survival and Overall Survival Analysis Methods and Critique” on Wednesday, 9th November at 09:00 CET. (HTA245) at #ISPOREurope
Read more here: bit.ly/3T1TWG3
#HEOR
















